Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xponential Fitness (XPOF) Other financing activities (2020 - 2025)

Xponential Fitness (XPOF) has disclosed Other financing activities for 6 consecutive years, with -$663000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities fell 250.79% year-over-year to -$663000.0, compared with a TTM value of -$2.8 million through Dec 2025, down 1497.54%, and an annual FY2025 reading of -$2.8 million, down 2299.22% over the prior year.
  • Other financing activities was -$663000.0 for Q4 2025 at Xponential Fitness, down from -$199000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $692000.0 in Q2 2021 and bottomed at -$7.9 million in Q1 2023.
  • Average Other financing activities over 5 years is -$556058.8, with a median of $3000.0 recorded in 2022.
  • Peak annual rise in Other financing activities hit 9766.67% in 2023, while the deepest fall reached 17350.0% in 2023.
  • Year by year, Other financing activities stood at $92000.0 in 2021, then crashed by 153.26% to -$49000.0 in 2022, then surged by 704.08% to $296000.0 in 2023, then plummeted by 163.85% to -$189000.0 in 2024, then crashed by 250.79% to -$663000.0 in 2025.
  • Business Quant data shows Other financing activities for XPOF at -$663000.0 in Q4 2025, -$199000.0 in Q3 2025, and -$1.1 million in Q2 2025.